CN1121811A - Drug prescription for treatment of neurosis and preparing method thereof - Google Patents
Drug prescription for treatment of neurosis and preparing method thereof Download PDFInfo
- Publication number
- CN1121811A CN1121811A CN 94104052 CN94104052A CN1121811A CN 1121811 A CN1121811 A CN 1121811A CN 94104052 CN94104052 CN 94104052 CN 94104052 A CN94104052 A CN 94104052A CN 1121811 A CN1121811 A CN 1121811A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- radix
- add
- rotundine
- prescription
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims description 27
- 238000000034 method Methods 0.000 title claims description 20
- 238000011282 treatment Methods 0.000 title claims description 16
- 206010029333 Neurosis Diseases 0.000 title description 18
- 208000015238 neurotic disease Diseases 0.000 title description 18
- 229940079593 drug Drugs 0.000 title description 5
- 239000000843 powder Substances 0.000 claims abstract description 29
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 claims description 36
- 239000011720 vitamin B Substances 0.000 claims description 30
- 229930003270 Vitamin B Natural products 0.000 claims description 29
- 235000019156 vitamin B Nutrition 0.000 claims description 29
- 244000293323 Cosmos caudatus Species 0.000 claims description 21
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 21
- 210000000582 semen Anatomy 0.000 claims description 19
- 229930189907 rotundine Natural products 0.000 claims description 18
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 15
- 239000008194 pharmaceutical composition Substances 0.000 claims description 15
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 241000208340 Araliaceae Species 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 241000756943 Codonopsis Species 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 238000009495 sugar coating Methods 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- -1 drying Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims description 2
- 239000008589 Cortex Fraxini Substances 0.000 claims description 2
- 240000001008 Dimocarpus longan Species 0.000 claims description 2
- 235000000235 Euphoria longan Nutrition 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims description 2
- 241000222336 Ganoderma Species 0.000 claims description 2
- 241000180649 Panax notoginseng Species 0.000 claims description 2
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 2
- 108010052008 colla corii asini Proteins 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 210000003038 endothelium Anatomy 0.000 claims description 2
- 239000010271 massa medicata fermentata Substances 0.000 claims description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000010025 steaming Methods 0.000 claims description 2
- 241000345998 Calamus manan Species 0.000 claims 1
- 229940126678 chinese medicines Drugs 0.000 claims 1
- 238000002481 ethanol extraction Methods 0.000 claims 1
- 235000012950 rattan cane Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 16
- 208000002173 dizziness Diseases 0.000 abstract description 11
- 206010019233 Headaches Diseases 0.000 abstract description 8
- 206010029216 Nervousness Diseases 0.000 abstract description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 8
- 206010022437 insomnia Diseases 0.000 abstract description 8
- 231100000869 headache Toxicity 0.000 abstract description 7
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 206010027175 memory impairment Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 12
- 230000006870 function Effects 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 208000019901 Anxiety disease Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000036506 anxiety Effects 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003340 mental effect Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 241000218176 Corydalis Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 206010012335 Dependence Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 230000004799 sedative–hypnotic effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002869 Anxiety symptoms Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- 206010013754 Drug withdrawal syndrome Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940125713 antianxiety drug Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000011262 co‐therapy Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000003784 masticatory muscle Anatomy 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000036403 neuro physiology Effects 0.000 description 1
- 230000000508 neurotrophic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008807 pathological lesion Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000004189 reticular formation Anatomy 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese-medicinal prescriptions for curing nervous diseases such as insomnia, disturbed sleep, headache, dizziness and hypomnesia with optimal curative effect is prepared from pearl powder, wild jujube seed, tuckahoe, VB1 and VB6.
Description
The present invention relates to one group and treat neurosal pharmaceutical formulation and preparation and method for making.
Neurosis is one group of commonly encountered diseases due to the human central nervous system function disorder, frequently-occurring disease.In neural psychiatric department outpatient service, neurosis accounts for 50%, and in internal medicine or other clinical sections, neurosis is also not rare, suffers from neurasthenic patient, insomnia, dreaminess, dizziness, headache, hypomnesis, can reduce study and work efficiency greatly, the anxiety of serious symptom and depression more have a strong impact on people's physical and mental health, therefore, seek the good and few side effects of a kind of curative effect calmness, calm the nerves, hypnotic drug is the world of medicine's urgent task for a long time.At present the neurosal medicine of this class of treatment is more, and as barbiturates sedative hypnotic, benzodiazepine antianxiety drugs etc., these medicines all are to be main therapeutic purposes to suppress that the central nervous system is overexcited.Obtained many achievements recent decades, but this class medicine all has many shortcomings, as addiction, toleration and sequela shape etc., its basic reason is still to fail to reach to make disorderly central nervous system function recover normal.Modern medicine study shows, neurosis be since the central nervous system because of damage, pathological changes or lack due to the physiological or pathologic obstacle that some nutrient substance takes place, recover normal nervous function, the undue excited neural while must suppressed, replenish essential neurotrophic material, thereby reach invigorating brain and relieving mental uneasiness, the purpose of taking stopgap measures and effecting a permanent cure.Purpose of the present invention just is to develop one group of drug compound preparation with above-mentioned effect, treating both the principal and secondary aspects of a disease, thus solve this class treatment of diseases difficult problem.
The object of the present invention is achieved like this, selects Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B for use
1, vitamin B
6, rhizoma corydalis extract or rotundine form compound preparation, this compound preparation has comprehensive functions such as calmness, hypnosis, analgesia, anxiety, and have brain-strengthening, calm the nerves, splendid curative effect such as liver heat removing and eyesight improving.Margarita layer powder suppressing the hyperactive liver and subsiding YANG, arresting convulsion are calmed the nerves in the side, and the Semen Ziziphi Spinosae tonifying liver nourishes blood, invigorating brain and relieving mental uneasiness, Poria spleen invigorating invigorating middle warmer, mind tranquilizing and the heart calming, promoting diuresis to eliminate damp pathogen, vitamin B
1And vitamin B
6All be that nervous system is kept the necessary coenzyme of normal physiological function, vitamin B
1The activity that can suppress acetylcholine esterase reduces the hydrolysis of acetylcholine, nerve conduction obstacle, the digestive function that recovers to cause because of nervous disorder symptom such as go down.Vitamin B
6Be the coenzyme of glutamate decarboxylase, this enzyme can become r-aminobutyric acid (GABA) by the catalysis glutamic acid rotating, and this reaction is a rate-limiting step, significance is arranged on neuro physiology, and GABA when content is low in the maincenter inhibitory transmitter brain, can cause mental excitation, even faint from fear vitimin supplement B
6, helping to make the normal rotundine of mental excitation glucose recovery that causes the decline of GABA content to cause because of maladjusted nervous system is the extract of traditional Chinese medicine corydalis tuber, studies show that this product has pain relieving and sedative-hypnotic effect.This prescription is got the dosage of its tranquilizing soporific, suppress the function of reticular formation of brain stem ascending activating system by it, make itself and other drug that synergism take place mutually, the co-therapy neurosis, in addition, Margarita layer powder, Semen Ziziphi Spinosae and Poria also contain the necessary all kinds of materials of abundant neurotrophy, comprise several amino acids and trace element, therefore, cooperatively interacting of these materials can suppress can replenish the essential all kinds of materials of neurocyte physiology again because of the disorderly neurosiss such as neural excitation that cause of nervous function, help it to recover normal function, promptly both took stopgap measures, effected a permanent cure again, thereby formed best pharmaceutical formulation
This compound preparation can be by following method preparation
1, gets Semen Ziziphi Spinosae, Poria Chinese medicine, pulverize, use soak with ethanol 24h, filter, reclaim ethanol, it is standby to get ethanol extract, and medicinal residues add the water steaming and decocting three times again, merge three times filtrate, filters, and filtrate is concentrated in right amount, add Margarita layer powder and ethanol extract, and suitable adjuvant, vitamin B is added in dry, pulverizing again
1, vitamin B
6With rotundine powder, mix homogeneously, be ground into fine powder again, make granule, tabletting sugar coating or promptly encapsulated
2, get above-mentioned Chinese medicine and pulverize, decoct with water three times, boiled back 1 hour at every turn, filter, merge three times filtrate, concentrate the suitable adjuvant after drying of adding and add Margarita layer powder, vitamin B
1Vitamin B
6And rotundine powder mix homogeneously, be ground into fine powder again, make granule, tabletting, sugar coating or encapsulated.
With the capsule that said method is made, every 200mg contains Margarita layer powder and Chinese medicine extract 150mg, rotundine 25mg, vitamin B
112.5mg, vitamin B
612.5mg.Be that its ratio is Margarita layer powder and Chinese medicine extract, rotundine, vitamin B
1, vitamin B
6Be respectively 12: 2: 1: 1
Through the zoopery proof good sedative sedative action is arranged with pharmaceutical formulation of the present invention, spontaneous activity to animal has significant inhibitory effect, passive activity to animal also has the obvious suppression effect, can obviously prolong and defend the mouse sleep time of crust due to the appropriate sodium, and heavy dose does not cause Animal Anesthesia, significant analgesia role is still arranged in addition, the long-term continuous application of rat 3 months, each vitals such as routine blood test, routine urinalysis, liver, renal function and the heart, liver, kidney, lung, spleen, stomach, intestinal are not all found pathologic lesion
Make " Margarita ANSHEN JIAONANG " with pharmaceutical formulation of the present invention, observe the therapeutic effect of 80 routine patients with neurosis at the court's department of neurology through strictness, the result shows that to neurosal symptom control curative effect be: the Cure for insomnia effective percentage is 88.8%; Dream many 77%; Dizzy 78%; Headache 78.3%; Anxiety symptom control effective percentage reaches 95%; Depressive symptom 83.4%; Nervous 74%; Attention laxes 33.3%; Hypomnesis 40%.Effective percentage to all kinds of disease treatments is: the neurasthenia 91.8%; Anxiety neurosis 100%; Nerve depression 100%; Total effective rate 93.8%
Side effect to this product is observed, do not find significant side effects, the patient takes medicine 1～2/time, and clothes backs does not have dizziness due to other tranquilizer, side effect such as drowsy, and increases deep sleep, patient's aftersensation of waking up gets that mind is clear-headed especially to be in the best of spirit, and the sensation of " eye clear order bright " is arranged, and individual patient can have slightly tired, phenomenons such as drowsy or xerostomia, but the very fast alleviation of symptom does not influence daily life and work and study.Observation shows that this product does not have addiction, toleration and withdrawal symptom, is the good prescription of the neurosal spy of treatment.
This preparation is added some Chinese prescription, and is better to some neurosis effect.Now be exemplified below:
One, to neurosal optimum formula based on " insomnia ":
Patient's insomnia of this disease is generally difficulty falling asleep.Patient often tosses about, dysphoria, can't fall asleep, the nose heave body of side in early morning is weary, sleepiness is not removed yet, have dizzy spells daytime, worries not sleep wellly again to night, forms vicious cycle, some patient-side performance sleep is shallow, easily wake up with a start, many nightmares.This class patient can add that Radix Polygalae, Semen Juglandis, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) are formed optimum formula (1) or adds Rhizoma Chuanxiong and vitamin C on the basis of above-mentioned basic prescription, forms optimum formula (2), and Chinese medicine of these two prescriptions press preceding method extraction, vitamin C and vitamin B
1, vitamin B
6Add together, this two side is good to the neurosis curative effect spy based on insomnia
Two, to neurosal optimum formula based on " anxiety or depression "
This disease patient usually upset, insecure, with a heavy heart, with knitted brows, be on tenterhooks, helpless, often with sleep and the unsettled phenomenon of autonomic nervous system, i.e. so-called " anxiety neurosis ", melancholy passive emotion also takes place in some patient, and this class patient adds Ganoderma, Radix Polygalae, Rhizoma Gastrodiae composition optimum formula (3) or adds Caulis Sinomenii, Radix Ginseng, Radix Scrophulariae and oryzanol and form optimum formula (4) on the basis of above-mentioned basic prescription, the Chinese medicine of these two prescriptions is pressed preceding method and is extracted, oryzanol and vitamin B
1, vitamin B
6Add together, through clinical observation, this two side is that the neurosis curative effect led is good to anxiety or depression, and obvious effective rate is higher widely than former side.
Three, to neurosal optimum formula based on " mental fatigue ":
This disease patient often tells inefficiency, difficult concentrating, the time, long slightly i.e. sense was dizzy, fatigue and weak, can't adhere to, hypomnesis, it is the most obvious to go down with short term memory power especially, in addition, patient is often with inappetence, acra cold and cyanosis, hyposexuality, irregular menses or amenorrhea.This class patient is on the basis of above-mentioned basic prescription, after adding Radix Ginseng, Fructus Schisandrae Chinensis, Herba Patriniae, Rhizoma Cyperi, Ramulus Cinnamomi, Radix Bupleuri composition optimum formula (5) extract Chinese medicine by preceding method, add in this basis side, this product is to being that the neurosis curative effect of primary symptom is better with the mental fatigue type.
Four, to neurosal optimum formula based on nervousness
This disease patient emotional lability, tired make an uproar, irritability, shortage patience, often because of minor matter and people's quarrel, work lacks main threads, stimulate to external world as sound, light etc. responsive especially, often disturbed their work and sleep anger because of this class stimulation, sleep shallow and dreaminess.Sensation strengthens in the body, often feel the five internal organs uneasiness, malasia, particularly owing to neck flesh, masticatory muscles, the nervous headache that causes of temporalis often are the main suits that this class patient gives prominence to, the characteristics of this headache are just as rest pain head is with lock ring, side, this class patient this basis commonly used adds Folium et Ramulus Clerodendri Trichotomi, Cortex Moutan, Periostracum Cicadae, Semen Coicis, Radix Gentianae Macrophyllae, Cortex Fraxini composition optimum formula (6), after the Chinese medicine of this prescription is partly pressed preceding method extraction preparation, add in the side, this basis, this product is better to the neurosis curative effect based on nervousness.
Five, to the neurosal optimum formula of traditional Chinese medical science typing based on " yang hyperactivity ":
This disease patient often shows as yang hyperactivity phenomenons such as headache, dizziness, dizzy or tinnitus, irritability, pulse condition be strong; can on the basis of side, this basis, increase Flos Chrysanthemi, Ramulus Uncariae Cum Uncis, Herba Ecliptae, Fructus Ligustri Lucidi, the Radix Paeoniae Alba, Radix Rehmanniae composition optimum formula (7); the Chinese medicine of this prescription partly is equipped with extraction by preceding legal system; add in the above-mentioned basis side, this side is preferable to yang-excess type neurastheniac curative effect through clinic trial.
Six, to the neurosal optimum formula of traditional Chinese medical science typing based on " weakness "
This disease patient often shows as weak phenomenons such as dizziness, fatigue and lack of strength, cardiopalmus, lusterless complexion, pulse condition are unable, sore waist and aching in the waist and the back, can on our basis, increase Radix Codonopsis, the Radix Astragali, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Fructus Schisandrae Chinensis, Arillus Longan, Radix Rehmanniae Preparata composition optimum formula (8), the Chinese medicine of this prescription is partly by after preceding method preparation and extracting, add in the above-mentioned basis side, this side is that main neurastheniac's curative effect is preferable through clinic trial to " weakness "
Seven, to the neurosal optimum formula due to the gastrointestinal upset
This disease patient is often based on inappetence, often tell in nauseating, vomiting, flatulence, uncomfortable in chest, insomnia, the vexed dim gas of gastral cavity, the abdomen distension a series of neurosiss, this class patient of causing such as not well of not relaxing or defecate and to add on the basis of above-mentioned basic recipe that Fructus Crataegi, Radix Et Rhizoma Rhei, Caulis Sinomenii, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Massa Medicata Fermentata form optimum formula (9) or add that Fructus Hordei Germinatus, Endothelium Corneum Gigeriae Galli, Radix Ophiopogonis, Radix Adenophorae (Radix Glehniae), the Radix Rehmanniae, Rhizoma Dioscoreae, Radix Panacis Quinquefolii form optimum formula (10).After Chinese medicine of these two prescriptions partly extracted by preceding method, it was preferable to the neurosis curative effect because of " due to the gastrointestinal upset " through clinic trial to add in the above-mentioned basic prescription this side.
Eight, to because of " anemia " and due to neurosal optimum formula
The common palor of this disease patient, lusterless complexion, lassitude and weak, dizzy, tinnitus, hypomnesis and anemia such as absent-minded are that main this class of symptom patient can be on the basis of aforementioned basic recipe, add the Radix Astragali, Radix Angelicae Sinensis, the Radix Rehmanniae, Fructus Corni, Radix Notoginseng, Fructus Jujubae, Caulis Spatholobi is formed optimum formula (11) or adds Radix Rehmanniae Preparata, Fructus Ligustri Lucidi, Rhizoma Polygoni Cuspidati, Radix Ginseng Rubra, Fructus Lycii, Fructus Psoraleae, Colla Corii Asini, the Radix Polygoni Multiflori is formed optimum formula (12), after the Chinese medicine of these two prescriptions partly extracts preparation by aforesaid technology, add in the above-mentioned basis side, this two side is that neurosis curative effect due to main is preferable through clinic trial to anemia.
In sum, with Margarita layer powder, Semen Ziziphi Spinosae, Poria, Rhizoma Corydalis extract or rotundine, vitamin B
1And vitamin B
6The neurosal compound preparation of treatment for the basis composition, neurosiss such as the insomnia due to a variety of causes, headache, dizziness, dreaminess, hypomnesis had splendid therapeutic effect, add some other drugs on this basis, better to the neurosis curative effect of some special type
Above-mentioned 12 kinds of optimum formulas except that basic components of enumerating can be made tablet or capsule confession oral application by aforementioned technology 1 or 2, and partly preparation can be made injection and be used for clinical through further technological transformation
Claims (10)
1, neurosal pharmaceutical formulation of a kind of treatment and method for making thereof is characterized in that this prescription contains Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B
1, vitamin B
6, rotundine.This prescription can be by following two kinds of prepared:
A, get that Chinese medicines such as Semen Ziziphi Spinosae, Poria are pulverized, ethanol extractions, medicinal residues steaming and decocting three times is again filtered, and merges three times filtrate, is concentrated in right amount, adds Margarita layer powder and ethanol extract, and suitable adjuvant, drying, and vitamin B is added in pulverizing again
1, vitamin B
6With rotundine powder, mix homogeneously, be ground into fine powder again, make granule, tabletting, sugar coating or promptly encapsulated;
B, get Chinese medicine and pulverize, decoct with water three times, filter, concentrate, add and live, add Margarita layer powder, vitamin B when the adjuvant after drying
1, vitamin B
6And rotundine powder mix homogeneously, be ground into fine powder again, make granule, tabletting, sugar coating or encapsulated, promptly
2, the neurosal pharmaceutical formulation of treatment as claimed in claim 1 is characterized in that the optimal proportion of the medicine composition of this prescription is Chinese medicine and Margarita layer powder 12: rotundine 2: vitamin B
11: vitamin B
61; Promptly 12: 2: 1: 1.
3, neurosal pharmaceutical formulation of treatment as claimed in claim 1 and method for making thereof is characterized in that the optimum formula of this prescription can be with Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B
1, vitamin B
6With rotundine be on the basis of basic components, add Radix Polygalae again, Semen Juglandis and Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae); Or add Rhizoma Chuanxiong and vitamin C.
4, neurosal pharmaceutical formulation of treatment as claimed in claim 1 and method for making thereof is characterized in that the optimum formula of this prescription can be with Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B
1, vitamin B
6With rotundine be on the basis of basic components, add Ganoderma, Radix Polygalae and Rhizoma Gastrodiae or add Caulis Sinomenii, Radix Ginseng, Radix Scrophulariae and oryzanol.
5, neurosal pharmaceutical formulation of treatment as claimed in claim 1 and method for making thereof is characterized in that the optimum formula of this prescription can be with Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B
1, vitamin B
6With rotundine be on the basis of basic components, add Radix Ginseng again.Fructus Schisandrae Chinensis, Herba Patriniae, Rhizoma Cyperi, Ramulus Cinnamomi, Radix Bupleuri.
6, neurosal pharmaceutical formulation of treatment as claimed in claim 1 and method for making thereof is characterized in that the optimum formula of this prescription can be with Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B
1, vitamin B
6With rotundine be on the basis of basic components, add Folium et Ramulus Clerodendri Trichotomi, Cortex Moutan, Periostracum Cicadae, Semen Coicis, Radix Gentianae Macrophyllae, Cortex Fraxini again.
7, neurosal pharmaceutical formulation of treatment as claimed in claim 1 and method for making thereof is characterized in that the optimum formula of this prescription can be with Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B
1, vitamin B
6With rotundine be on the basis of basic components, add Flos Chrysanthemi, an ancient unit of weight rattan, Herba Ecliptae, Fructus Ligustri Lucidi, the Radix Paeoniae Alba, the Radix Rehmanniae again.
8, neurosal pharmaceutical formulation of treatment as claimed in claim 1 and method for making thereof is characterized in that the optimum formula of this prescription can be with Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B
1, vitamin B
6With rotundine be on the basis of basic components, add Radix Codonopsis, the Radix Astragali, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Fructus Schisandrae Chinensis, Arillus Longan, Radix Rehmanniae Preparata again.
9, neurosal pharmaceutical formulation of treatment as claimed in claim 1 and method for making thereof is characterized in that the optimum formula of this prescription can be with Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B
1, vitamin B
6With rotundine be on the basis of basic components, add Fructus Crataegi, Radix Et Rhizoma Rhei, Caulis Sinomenii, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Massa Medicata Fermentata again or add Fructus Hordei Germinatus, Endothelium Corneum Gigeriae Galli, Radix Ophiopogonis, the Radix Rehmanniae, Radix Adenophorae (Radix Glehniae), Rhizoma Dioscoreae, Radix Panacis Quinquefolii again.
10, neurosal pharmaceutical formulation of treatment as claimed in claim 1 and method for making thereof is characterized in that the optimum formula of this prescription can be with Margarita layer powder, Semen Ziziphi Spinosae, Poria, vitamin B
1, vitamin B
6With rotundine be on the basis of basic components, add the Radix Astragali, Radix Angelicae Sinensis, the Radix Rehmanniae, Fructus Corni, Radix Notoginseng, Fructus Jujubae, Caulis Spatholobi again or add Radix Rehmanniae Preparata, Fructus Ligustri Lucidi, Rhizoma Polygoni Cuspidati, Radix Ginseng Rubra, Fructus Lycii, Fructus Psoraleae, Colla Corii Asini, the Radix Polygoni Multiflori again.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94104052 CN1121811A (en) | 1994-05-12 | 1994-05-12 | Drug prescription for treatment of neurosis and preparing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94104052 CN1121811A (en) | 1994-05-12 | 1994-05-12 | Drug prescription for treatment of neurosis and preparing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1121811A true CN1121811A (en) | 1996-05-08 |
Family
ID=5031399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94104052 Pending CN1121811A (en) | 1994-05-12 | 1994-05-12 | Drug prescription for treatment of neurosis and preparing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1121811A (en) |
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1299758C (en) * | 2003-08-07 | 2007-02-14 | 汕头市思济药业有限公司 | Anti-depression traditional medicinal composition and its preparation method |
| CN100340272C (en) * | 2005-06-15 | 2007-10-03 | 白云新 | Headache-treating medicine |
| CN100353984C (en) * | 2004-08-09 | 2007-12-12 | 云南盘龙云海药业有限公司 | Pharmaceutical composition and preparation method thereof |
| CN100490883C (en) * | 2006-01-24 | 2009-05-27 | 殷家福 | Drug of gastrodia elata for invigorating brain |
| CN1383837B (en) * | 2001-05-09 | 2010-05-12 | 张之道 | Composite medicine for treating cardiac and cerebral vascular disease and its production process |
| CN102008561A (en) * | 2010-12-09 | 2011-04-13 | 上海市精神卫生中心 | Mixture for treating depression |
| CN102319378A (en) * | 2011-09-09 | 2012-01-18 | 首都医科大学附属北京安定医院 | Chinese medicinal composition for antagonizing side effect caused by chlorpromazine and preparation method thereof |
| CN102657783A (en) * | 2012-03-15 | 2012-09-12 | 周玉萍 | Drug for treating involutional psychosis |
| CN102716256A (en) * | 2012-06-21 | 2012-10-10 | 陈慧婷 | Rehmannia glutinosa traditional Chinese medicine preparation for treating headache and its preparation method |
| CN102988684A (en) * | 2012-10-30 | 2013-03-27 | 严中明 | Traditional Chinese medicine composition for treating neurasthenia |
| CN103110805A (en) * | 2013-01-09 | 2013-05-22 | 胡夫东 | Traditional Chinese medicine composition for treating manic episodes caused by mood disorders and preparation method thereof |
| CN103142974A (en) * | 2013-03-22 | 2013-06-12 | 徐道慧 | Medicament for treating anxiety disorder |
| CN103142969A (en) * | 2013-03-22 | 2013-06-12 | 高新华 | Medicament for treating dysthymia |
| CN103191253A (en) * | 2013-04-18 | 2013-07-10 | 陆娜 | Medicine for treating anemia and preparation method thereof |
| CN103211998A (en) * | 2013-03-18 | 2013-07-24 | 赵霞 | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess |
| CN103341075A (en) * | 2013-07-29 | 2013-10-09 | 付庆涛 | Traditional Chinese medicine pills for treating neurasthenia |
| CN103719275A (en) * | 2013-12-16 | 2014-04-16 | 马鞍山市安康菌业有限公司 | Banana milk drink and preparation method thereof |
| CN103961578A (en) * | 2014-05-15 | 2014-08-06 | 吴春来 | Traditional Chinese medicine medicinal liquor for treating neurasthenia |
| CN104306525A (en) * | 2014-10-23 | 2015-01-28 | 张益玲 | Traditional Chinese medicine preparation for treating neurasthenia |
| CN104906310A (en) * | 2015-06-09 | 2015-09-16 | 徐艳 | Medicine granules for treating neurasthenia |
| CN106177415A (en) * | 2016-08-22 | 2016-12-07 | 肖华 | The Chinese and western medicinal composition of a kind for the treatment of of insomnia patients and preparation method |
| CN107296943A (en) * | 2017-06-15 | 2017-10-27 | 合肥川迪医药技术有限公司 | The antidepression prescription and its instructions of taking of dispersing stagnated hepatoqi |
| CN107638544A (en) * | 2017-09-30 | 2018-01-30 | 张衡 | A kind of herbal mixture for treating depression |
| CN112755074A (en) * | 2021-01-21 | 2021-05-07 | 上海普康药业有限公司 | Pharmaceutical composition containing oryzanol and preparation method and application thereof |
-
1994
- 1994-05-12 CN CN 94104052 patent/CN1121811A/en active Pending
Cited By (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1383837B (en) * | 2001-05-09 | 2010-05-12 | 张之道 | Composite medicine for treating cardiac and cerebral vascular disease and its production process |
| CN1299758C (en) * | 2003-08-07 | 2007-02-14 | 汕头市思济药业有限公司 | Anti-depression traditional medicinal composition and its preparation method |
| CN100353984C (en) * | 2004-08-09 | 2007-12-12 | 云南盘龙云海药业有限公司 | Pharmaceutical composition and preparation method thereof |
| CN100340272C (en) * | 2005-06-15 | 2007-10-03 | 白云新 | Headache-treating medicine |
| CN100490883C (en) * | 2006-01-24 | 2009-05-27 | 殷家福 | Drug of gastrodia elata for invigorating brain |
| CN102008561A (en) * | 2010-12-09 | 2011-04-13 | 上海市精神卫生中心 | Mixture for treating depression |
| CN102319378A (en) * | 2011-09-09 | 2012-01-18 | 首都医科大学附属北京安定医院 | Chinese medicinal composition for antagonizing side effect caused by chlorpromazine and preparation method thereof |
| CN102657783A (en) * | 2012-03-15 | 2012-09-12 | 周玉萍 | Drug for treating involutional psychosis |
| CN102657783B (en) * | 2012-03-15 | 2013-08-07 | 周玉萍 | Drug for treating involutional psychosis |
| CN102716256A (en) * | 2012-06-21 | 2012-10-10 | 陈慧婷 | Rehmannia glutinosa traditional Chinese medicine preparation for treating headache and its preparation method |
| CN102716256B (en) * | 2012-06-21 | 2013-09-11 | 陈慧婷 | Prepared rehmannia root Chinese medicinal preparation for treating headache and preparation method thereof |
| CN102988684A (en) * | 2012-10-30 | 2013-03-27 | 严中明 | Traditional Chinese medicine composition for treating neurasthenia |
| CN102988684B (en) * | 2012-10-30 | 2015-07-29 | 严中明 | One treats neurasthenic Chinese medicine composition |
| CN103110805A (en) * | 2013-01-09 | 2013-05-22 | 胡夫东 | Traditional Chinese medicine composition for treating manic episodes caused by mood disorders and preparation method thereof |
| CN103211998A (en) * | 2013-03-18 | 2013-07-24 | 赵霞 | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess |
| CN103211998B (en) * | 2013-03-18 | 2014-08-20 | 赵霞 | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess |
| CN103142974A (en) * | 2013-03-22 | 2013-06-12 | 徐道慧 | Medicament for treating anxiety disorder |
| CN103142974B (en) * | 2013-03-22 | 2014-04-30 | 张勇 | Medicament for treating anxiety disorder |
| CN103142969A (en) * | 2013-03-22 | 2013-06-12 | 高新华 | Medicament for treating dysthymia |
| CN103191253A (en) * | 2013-04-18 | 2013-07-10 | 陆娜 | Medicine for treating anemia and preparation method thereof |
| CN103341075B (en) * | 2013-07-29 | 2015-01-07 | 临沂大学 | A traditional Chinese medicine pill for treating neurasthenia |
| CN103341075A (en) * | 2013-07-29 | 2013-10-09 | 付庆涛 | Traditional Chinese medicine pills for treating neurasthenia |
| CN103719275A (en) * | 2013-12-16 | 2014-04-16 | 马鞍山市安康菌业有限公司 | Banana milk drink and preparation method thereof |
| CN103961578A (en) * | 2014-05-15 | 2014-08-06 | 吴春来 | Traditional Chinese medicine medicinal liquor for treating neurasthenia |
| CN104306525A (en) * | 2014-10-23 | 2015-01-28 | 张益玲 | Traditional Chinese medicine preparation for treating neurasthenia |
| CN104906310A (en) * | 2015-06-09 | 2015-09-16 | 徐艳 | Medicine granules for treating neurasthenia |
| CN106177415A (en) * | 2016-08-22 | 2016-12-07 | 肖华 | The Chinese and western medicinal composition of a kind for the treatment of of insomnia patients and preparation method |
| CN107296943A (en) * | 2017-06-15 | 2017-10-27 | 合肥川迪医药技术有限公司 | The antidepression prescription and its instructions of taking of dispersing stagnated hepatoqi |
| CN107638544A (en) * | 2017-09-30 | 2018-01-30 | 张衡 | A kind of herbal mixture for treating depression |
| CN112755074A (en) * | 2021-01-21 | 2021-05-07 | 上海普康药业有限公司 | Pharmaceutical composition containing oryzanol and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1121811A (en) | Drug prescription for treatment of neurosis and preparing method thereof | |
| CN101732683A (en) | Chinese medicinal preparation for treating facial chloasma and preparation method thereof | |
| CN101711850B (en) | Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method | |
| CN102526474B (en) | Chinese medicine composition for treating neurasthenia | |
| CN102283999B (en) | Traditional Chinese medicine preparation for treating insomnia | |
| CN102406831B (en) | Chinese medicine composition for treating insomnia and dreamful sleep and preparation method of Chinese medicine composition | |
| CN100368006C (en) | Medicine for treating cardiovascular disease | |
| CN101549078A (en) | Pharmaceutical composition for treating intractable insomnia and preparation method thereof | |
| CN106728261A (en) | A kind of pharmaceutical composition for treating insomnia | |
| CN105535127A (en) | Foot bath powder containing folium artemisiae argyi dregs and achieving sleep improvement function and preparation method thereof | |
| CN101496890A (en) | Chinese medicinal composition for treating neurasthenia and preparation method thereof | |
| CN113842411A (en) | Traditional Chinese medicine composition of lucid ganoderma nerve-soothing capsule and preparation method thereof | |
| CN103230457B (en) | A kind of Chinese medicine composition treating viral myocarditis and preparation method thereof and purposes | |
| US11771727B2 (en) | Traditional Chinese medicine composition and product for improving sleep by balancing yin and yang, method for making the same and use thereof | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN104383420A (en) | Preparation method of pharmaceutical preparation for treating insomnia and dreaminess | |
| CN104383421A (en) | Pharmaceutical preparation for treating insomnia and dreaminess | |
| CN104225425A (en) | Chinese herbal preparation for enhancing immunity, improving sleep and preventing cardio-cerebrovascular disease, and preparation method thereof | |
| CN1111054C (en) | Medicine for treating apoplexy and its preparing process | |
| CN102441103B (en) | Medicine for treating insomnia | |
| CN102349979A (en) | Oral traditional Chinese medicine composition for treating bitter taste in mouth | |
| CN1425456A (en) | Nourishing wine for regulating human body balance function | |
| CN1255147C (en) | Oral liquid for preserving one's longevity | |
| CN105963505A (en) | Traditional Chinese medicinal foot bath powder capable of treating insomnia | |
| CN1709476A (en) | Yang Xin An Mian Capsules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |